Cargando…

Impact of Disease-Modifying Treatments of Multiple Sclerosis on Anti–SARS-CoV-2 Antibodies: An Observational Study

OBJECTIVE: To compare the humoral response after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in patients with multiple sclerosis (MS) receiving different disease-modifying treatments (DMTs). METHODS: Patients with MS with coronavirus disease 2019 (COVID-19) and available a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bigaut, Kévin, Kremer, Laurent, Fabacher, Thibaut, Lanotte, Livia, Fleury, Marie-Celine, Collongues, Nicolas, de Seze, Jerome
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8362343/ https://www.ncbi.nlm.nih.gov/pubmed/34321333 http://dx.doi.org/10.1212/NXI.0000000000001055

Ejemplares similares

Ocrelizumab versus fingolimod after natalizumab cessation in multiple sclerosis: an observational study
por: Bigaut, Kévin, et al.
Publicado: (2022)

Impact of disease-modifying treatments on humoral response after COVID-19 vaccination: A mirror of the response after SARS-CoV-2 infection
por: Bigaut, K., et al.
Publicado: (2021)

Resting-state functional MRI demonstrates brain network reorganization in neuromyelitis optica spectrum disorder (NMOSD)
por: Bigaut, Kévin, et al.
Publicado: (2019)

Frequency of myelin oligodendrocyte glycoprotein antibody in multiple sclerosis: A multicenter cross-sectional study
por: Cobo-Calvo, Álvaro, et al.
Publicado: (2019)

Guillain-Barré syndrome related to SARS-CoV-2 infection
por: Bigaut, Kévin, et al.
Publicado: (2020)

A Narrative Review on Axonal Neuroprotection in Multiple Sclerosis
por: Collongues, Nicolas, et al.
Publicado: (2022)

Evaluation of Clinical Interest of Anti-Aquaporin-4 Autoantibody Followup in Neuromyelitis Optica
por: Chanson, Jean-Baptiste, et al.
Publicado: (2013)

A rise in cases of nitrous oxide abuse: neurological complications and biological findings
por: Einsiedler, Maximilian, et al.
Publicado: (2021)

Real-World Effectiveness of Natalizumab Extended Interval Dosing in a French Cohort
por: Pelle, Juliette, et al.
Publicado: (2023)

Rapid Discrimination of Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis Using Machine Learning on Infrared Spectra of Sera
por: El Khoury, Youssef, et al.
Publicado: (2022)

Inflammatory-like presentation of CADASIL: a diagnostic challenge
por: Collongues, Nicolas, et al.
Publicado: (2012)

The TOTEM RRMS (Testosterone Treatment on neuroprotection and Myelin Repair in Relapsing Remitting Multiple Sclerosis) trial: study protocol for a randomized, double-blind, placebo-controlled trial
por: Metzger-Peter, Katline, et al.
Publicado: (2020)

Biomarkers of treatment response in patients with progressive multiple sclerosis treated with high‐dose pharmaceutical‐grade biotin (MD1003)
por: Collongues, Nicolas, et al.
Publicado: (2020)

Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection
por: Gallais, Floriane, et al.
Publicado: (2021)

Chronic Bickerstaff’s encephalitis with cognitive impairment, a reality?
por: Renaud, Mathilde, et al.
Publicado: (2014)

COVID-19 exposure in SARS-CoV-2-seropositive hospital staff members during the first pandemic wave at Strasbourg University Hospital, France
por: Velay, Aurélie, et al.
Publicado: (2022)

Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype
por: Pröbstel, Anne-Katrin, et al.
Publicado: (2015)

The Translatability of Multiple Sclerosis Animal Models for Biomarkers Discovery and Their Clinical Use
por: Birmpili, Dafni, et al.
Publicado: (2022)

Neutralizing antibodies and fatigue as predictors of low response to interferon-beta treatment in patients with multiple sclerosis
por: Manceau, Philippe, et al.
Publicado: (2014)

Patient perceptions of multiple sclerosis and its treatment
por: de Seze, Jérôme, et al.
Publicado: (2012)

Teriflunomide in Patients with Relapsing–Remitting Forms of Multiple Sclerosis
por: Chan, Andrew, et al.
Publicado: (2016)

Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern France
por: Fafi-Kremer, Samira, et al.
Publicado: (2020)

Double-Blind Controlled Randomized Trial of Cyclophosphamide versus Methylprednisolone in Secondary Progressive Multiple Sclerosis
por: Brochet, Bruno, et al.
Publicado: (2017)

Safety of disease-modifying treatments in SARS-CoV-2 antibody-positive multiple sclerosis patients
por: Mallucci, Giulia, et al.
Publicado: (2021)

Cognitive Dysfunction and Dementia in Primary Sjögren's Syndrome
por: Blanc, Frederic, et al.
Publicado: (2013)

White Matter Atrophy and Cognitive Dysfunctions in Neuromyelitis Optica
por: Blanc, Frederic, et al.
Publicado: (2012)

Multiplex assays for the identification of serological signatures of SARS-CoV-2 infection: an antibody-based diagnostic and machine learning study
por: Rosado, Jason, et al.
Publicado: (2021)

Comparison of Footsteps Using Connected Bracelets with the Timed Up-and-Go Test and the 6-Minutes Walking Test in a Prospective Colorectal Surgery Cohort
por: Romain, Benoît, et al.
Publicado: (2020)

Implementation of an enhanced recovery program for complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a referral center: a case control prospective study
por: Charleux-Muller, Diane, et al.
Publicado: (2023)

Impact of multiple sclerosis disease-modifying therapies on SARS-CoV-2 vaccine-induced antibody and T cell immunity
por: Sabatino, Joseph J., et al.
Publicado: (2021)

Emotional experience is increased and emotion recognition decreased in multiple sclerosis
por: Pfaff, Line, et al.
Publicado: (2021)

Cognitive Impairment in Secondary Progressive Multiple Sclerosis: Effect of Disease Duration, Age, and Progressive Phenotype
por: Brochet, Bruno, et al.
Publicado: (2022)

The BAS(2)IC Score: A Useful Tool to Identify Patients at High Risk of Early Progression to Severe Coronavirus Disease 2019
por: Kaeuffer, Charlotte, et al.
Publicado: (2020)

Quantitative and qualitative normative dataset for intraepidermal nerve fibers using skin biopsy
por: Collongues, Nicolas, et al.
Publicado: (2018)

Evaluation of the performance of SARS-CoV-2 serological tools and their positioning in COVID-19 diagnostic strategies
por: Velay, Aurelie, et al.
Publicado: (2020)

Outcome and risk of recurrence in a large cohort of idiopathic longitudinally extensive transverse myelitis without AQP4/MOG antibodies
por: Maillart, Elisabeth, et al.
Publicado: (2020)

Experimental Efficacy of the Face Shield and the Mask against Emitted and Potentially Received Particles
por: Wendling, Jean-Michel, et al.
Publicado: (2021)

FTY720 controls disease severity and attenuates sciatic nerve damage in chronic experimental autoimmune neuritis
por: Kremer, Laurent, et al.
Publicado: (2019)

Multiple sclerosis treatment blunts SARS-CoV-2 antibody response
por: Lemprière, Sarah
Publicado: (2021)

IgG antibody titers to SARS-CoV-2 reveal a distinct efficacy of multiple sclerosis-modifying therapies to curtail lymphocyte compartments
por: Wienands, Jürgen
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_voamvbas16ca6svj7knne5a15v